PTRF decreases VEGF-A and VEGF-C expression in prostate cancer cells and reduces their lymphangiogenic potential in vitro and in vivo. Nassar ZD, Moon H, Duong T, Hill MM, Francois M, Parton RG, Parat M.O (2015). In International Conference on Medical, Biological and Pharmaceutical Sciences, Kuala Lumpur, Malaysia.
PTRF decreases prostate cancer angiogenesis potential. Nassar ZD, Moon H, Duong T, Hill MM, Francois M, Parton RG, Parat M.O (2014). In 15th Asia-Pacific Prostate Cancer Conference. Melbourne, Australia.
Caveolin-1 modulates VEGF-A and VEGF-C expression and enhances prostate cancer lymphangiogenesis potential. Nassar, Z.D., Francois M, Parton RG, Parat M-O. (2014). In European Society for Medical Oncology (ESMO), Madrid, Spain.
Caveolin-1 induces the angiogenic potential of prostate cancer cells. Nassar, Z.D., Parat M.O. (2013). In Australian Society for Medical Research (ASMR), Brisbane, Australia.